Show simple item record

dc.contributor.authorJohannsson, G
dc.contributor.authorBidlingmaier, M
dc.contributor.authorBiller, B
dc.contributor.authorBoguszewski, M
dc.contributor.authorCasanueva, F
dc.contributor.authorChanson, P
dc.contributor.authorClayton, P
dc.contributor.authorChoong, C
dc.contributor.authorClemmons, D
dc.contributor.authorDattani, M
dc.contributor.authorFrystyk, J
dc.contributor.authorHo, K
dc.contributor.authorHoffman, A
dc.contributor.authorHorikawa, R
dc.contributor.authorJuul, A
dc.contributor.authorKopchick, J
dc.contributor.authorLuo, X
dc.contributor.authorNeggers, S
dc.contributor.authorNetchine, I
dc.contributor.authorOlsson, D
dc.contributor.authorRadovick, S
dc.contributor.authorRosenfeld, R
dc.contributor.authorRoss, R
dc.contributor.authorSchilbach, K
dc.contributor.authorSolberg, P
dc.contributor.authorStrasburger, C
dc.contributor.authorTrainer, Peter J
dc.contributor.authorYuen, K
dc.contributor.authorWickstrom, K
dc.contributor.authorJorgensen, J
dc.date.accessioned2018-04-28T20:52:34Z
dc.date.available2018-04-28T20:52:34Z
dc.date.issued2018-03
dc.identifier.citationGrowth Hormone Research Society perspective on biomarkers of GH action in children and adults. 2018, 7(3): R126-R134 Endocr Connecten
dc.identifier.issn2049-3614
dc.identifier.pmid29483159
dc.identifier.doi10.1530/EC-18-0047
dc.identifier.urihttp://hdl.handle.net/10541/620917
dc.description.abstractThe Growth Hormone Research Society (GRS) convened a Workshop in 2017 to evaluate clinical endpoints, surrogate endpoints and biomarkers during GH treatment of children and adults and in patients with acromegaly.
dc.language.isoenen
dc.rightsArchived with thanks to Endocrine connectionsen
dc.titleGrowth Hormone Research Society perspective on biomarkers of GH action in children and adults.en
dc.typeArticleen
dc.contributor.departmentDepartment of Internal Medicine and Clinical NutritionSahlgrenska Academy, University of Gothenburg, Gothenburg, Swedenen
dc.identifier.journalEndocrine Connectionsen
refterms.dateFOA2018-12-17T15:20:05Z
html.description.abstractThe Growth Hormone Research Society (GRS) convened a Workshop in 2017 to evaluate clinical endpoints, surrogate endpoints and biomarkers during GH treatment of children and adults and in patients with acromegaly.


Files in this item

Thumbnail
Name:
R126.full.pdf
Size:
530.6Kb
Format:
PDF
Description:
Full text, Open Access article

This item appears in the following Collection(s)

Show simple item record